An American company is looking to establish a pharmaceutical factory in the Suez Canal Economic Zone (SCZone), and a delegation from the company will be visiting Egypt “within the coming period” to discuss the project, SCZone chairman Ahmed Darwish said, according to the State Information Service. Darwish did not provide details on the company or the expected size of its investment.
More from Enterprise
Banque du Caire opens its IPO books at EGP 4.82-5.30 a share, with room to grow to 45%
The state-owned lender could raise up to EGP 36.4 bn,…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
FRA and EGX eye law change to let LLCs and partnerships set up investment funds
Regulators want to keep Egyptian money from setting up funds…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…